Contact: research@protoquiz.com

Statewide

Rhode Island Department of Health – Center for Emergency Medical Services

Current219 dose entries62 drugs4 documentsRIeffective 2026-06-01100% machine-parsed of 219

Drugs and doses62

A–C Acetaminophen, Adenosine, Albuterol, Amiodarone, Aspirin, Atropine, Buprenorphine, Calcium Chloride, Calcium Gluconate, Ceftriaxone, Cetirizine11

Acetaminophen

IndicationPopulationDoseRouteRepeatStandingSource
Fever adult 500–1000 mg PO not captured standing pages 68, 69 · source
Fever adult 500–1000 mg IV not captured standing pages 68, 69 · source
Fever peds 15 mg/kg PO not captured standing pages 68, 69 · source
Fever peds 15 mg/kg PR not captured standing page 69 · source
Fever peds 15 mg/kg IV not captured standing pages 68, 69 · source
Mild to moderate pain adult 500–1000 mg PO not captured standing pages 46, 49 · source
Mild to moderate pain adult 500–1000 mg IV not captured standing pages 46, 49, 50 · source
Mild to moderate pain peds 15 mg/kg PO not captured standing pages 46, 49 · source
Mild to moderate pain peds 15 mg/kg IV not captured standing pages 46, 49, 50 · source

Adenosine

IndicationPopulationDoseRouteRepeatStandingSource
Narrow-complex tachycardia adult 12 mg IV not captured standing pages 120, 122 · source
Narrow-complex tachycardia peds 0.2 mg/kg IV not captured standing pages 120, 122 · source
Wide-complex tachycardia adult 12 mg IV not captured standing page 124 · source
Wide-complex tachycardia peds 0.2 mg/kg IV not captured standing page 124 · source

Albuterol

IndicationPopulationDoseRouteRepeatStandingSource
Anaphylaxis adult 2.5–5 mg NEB not captured standing pages 35, 36, 37, 39, 40, 41 · source
Anaphylaxis peds 2.5–5 mg NEB not captured standing pages 35, 36, 37, 39, 40, 41 · source
Asthma / bronchospasm adult 2.5–5 mg NEB not captured standing pages 53, 55, 56 · source
Asthma / bronchospasm peds 2.5–5 mg NEB not captured standing pages 53, 55, 56 · source
Hyperkalemia adult 5 mg NEB not captured standing page 147 · source
Hyperkalemia peds 5 mg NEB not captured standing page 147 · source

Amiodarone

IndicationPopulationDoseRouteRepeatStandingSource
Atrial fibrillation with RVR adult 150 mg IV not captured standing pages 120, 126 · source
VF / pulseless VT adult 300 mg IV/IO not captured standing pages 104, 105, 113 · source
VF / pulseless VT peds 5 mg/kg IV/IO not captured standing pages 104, 105, 113 · source

Aspirin

IndicationPopulationDoseRouteRepeatStandingSource
ACS / chest pain adult 324 mg PO not captured standing pages 98, 100 · source

Atropine

IndicationPopulationDoseRouteRepeatStandingSource
Bradycardia adult 0.5–1 mg IV not captured standing pages 118, 119 · source
Bradycardia peds 0.02 mg/kg IV not captured standing pages 118, 119 · source
Nerve agent exposure adult 2 mg IV/IM not captured standing page 166 · source
Nerve agent exposure peds 0.02–0.05 mg/kg IV/IM not captured standing page 166 · source
Other adult 0.5 mg IV/IM not captured standing pages 59, 95 · source
Other peds 0.5 mg IV/IM not captured standing pages 59, 95 · source

Buprenorphine

IndicationPopulationDoseRouteRepeatStandingSource
Other adult 16 mg SL not captured standing page 209 · source

Calcium Chloride

IndicationPopulationDoseRouteRepeatStandingSource
Hyperkalemia adult 1 g IV not captured standing pages 63, 147 · source
Other adult 1 g IV not captured standing pages 161, 162, 164, 165 · source
Other adult 1 g IV not captured standing pages 164, 165 · source
Other peds 20 mg/kg IV not captured standing pages 161, 162, 164, 165 · source

Calcium Gluconate

IndicationPopulationDoseRouteRepeatStandingSource
Beta-blocker / calcium-channel-blocker overdose adult 3 g IV not captured standing pages 145, 161, 162, 164, 165 · source
Beta-blocker / calcium-channel-blocker overdose peds 60 mg/kg IV not captured standing pages 145, 161, 162, 164, 165 · source
Hyperkalemia adult 3 g IV not captured standing page 63 · source
Other adult 1 g IV not captured standing page 159 · source
Other peds 20 mg/kg IV not captured standing page 159 · source

Ceftriaxone

IndicationPopulationDoseRouteRepeatStandingSource
Other adult 2 g IV not captured standing page 139 · source
Other peds 50 mg/kg IV not captured standing page 139 · source

Cetirizine

IndicationPopulationDoseRouteRepeatStandingSource
Allergic reaction adult 10 mg PO not captured standing pages 36, 40 · source
Allergic reaction peds 10 mg PO not captured standing pages 36, 40 · source
D–F Dexamethasone, Dextrose, Diazepam, Diltiazem, Diphenhydramine, Dopamine, Droperidol, Enalaprilat, Epinephrine, Etomidate, Famotidine, Fat Emulsion, Fentanyl, Furosemide14

Dexamethasone

IndicationPopulationDoseRouteRepeatStandingSource
Adrenal crisis adult 10 mg IV not captured standing page 34 · source
Adrenal crisis peds 0.3 mg/kg IV not captured standing page 34 · source
Croup peds 0.6 mg/kg IV/IM/PO not captured standing page 56 · source
Respiratory distress adult 10–20 mg IV/IM not captured standing pages 53, 56 · source
Respiratory distress peds 0.6 mg/kg IV/IM not captured standing pages 53, 56 · source

Dextrose

IndicationPopulationDoseRouteRepeatStandingSource
Hypoglycemia adult 25 g IV not captured standing pages 61, 62, 71 · source
Hypoglycemia peds 2–4 mL/kg IV not captured standing pages 61, 62, 71 · source
Neonatal resuscitation peds 2–4 mL/kg IV not captured standing page 71 · source

Diazepam

IndicationPopulationDoseRouteRepeatStandingSource
Procedural sedation adult 2.5–5 mg IV/IM not captured standing pages 46, 47, 120, 124 · source
Seizure adult 2.5 mg IV/IN not captured standing pages 77, 79 · source
Seizure peds 0.1 mg/kg IV/IN not captured standing pages 77, 79 · source
Seizure peds 0.5 mg/kg PR not captured standing page 79 · source

Diltiazem

IndicationPopulationDoseRouteRepeatStandingSource
Narrow-complex tachycardia adult 0.25 mg/kg IV not captured standing page 120 · source

Diphenhydramine

IndicationPopulationDoseRouteRepeatStandingSource
Allergic reaction adult 50 mg PO not captured standing pages 35, 39 · source
Allergic reaction adult 50 mg IV/IM not captured standing pages 36, 37, 40, 41 · source
Allergic reaction peds 1 mg/kg PO not captured standing pages 35, 39 · source
Allergic reaction peds 1 mg/kg IV/IM not captured standing pages 36, 37, 40, 41 · source
Dystonic reaction adult 25–50 mg IV not captured standing pages 162, 165 · source
Dystonic reaction peds 1 mg/kg IV not captured standing pages 162, 165 · source

Dopamine

IndicationPopulationDoseRouteRepeatStandingSource
Bradycardia adult 2–10 mcg/kg IV not captured standing pages 118, 119 · source
Bradycardia peds 2–10 mcg/kg IV not captured standing pages 118, 119 · source
Cardiogenic shock adult 2–20 mcg/kg IV not captured standing page 82 · source
Hypotension / shock adult 2–20 mcg/kg IV not captured standing pages 81, 82 · source

Droperidol

IndicationPopulationDoseRouteRepeatStandingSource
Agitation adult 5–10 mg IV/IM not captured standing page 59 · source

Enalaprilat

IndicationPopulationDoseRouteRepeatStandingSource
CHF / pulmonary edema adult 1.25 mg IV not captured standing page 98 · source

Epinephrine

IndicationPopulationDoseRouteRepeatStandingSource
Anaphylaxis adult 0.3 mg IM not captured standing pages 35, 36, 37, 39, 40, 41 · source
Anaphylaxis peds 0.15 mg IM not captured standing pages 35, 36, 37, 39, 40, 41 · source
Bradycardia adult 2–10 mcg IV not captured standing pages 118, 119 · source
Bradycardia peds 10 mcg IV not captured standing pages 118, 119 · source
Cardiac arrest adult 1 mg IV/IO not captured standing pages 104, 105, 112, 113 · source
Cardiac arrest peds 0.01 mg/kg IV/IO not captured standing pages 104, 105, 112, 113 · source
Other adult 0.3 mg IM not captured standing pages 53, 55, 56 · source
Other peds 0.15–0.3 mg IM not captured standing pages 53, 55, 56 · source

Etomidate

IndicationPopulationDoseRouteRepeatStandingSource
RSI induction adult 0.2–0.3 mg/kg IV not captured standing page 187 · source

Famotidine

IndicationPopulationDoseRouteRepeatStandingSource
Allergic reaction adult 20–40 mg IV/PO not captured standing pages 37, 41 · source

Fat Emulsion

IndicationPopulationDoseRouteRepeatStandingSource
Other adult 1.5 mL/kg IV not captured standing pages 162, 165 · source
Other peds 1.5 mL/kg IV not captured standing pages 162, 165 · source

Fentanyl

IndicationPopulationDoseRouteRepeatStandingSource
Other peds 1.5–3 mcg/kg IV not captured standing pages 47, 50 · source
Severe pain adult 0.5–1 mcg/kg IV/IM/IN not captured standing pages 46, 47, 49, 50 · source
Severe pain peds 0.5–1 mcg/kg IV/IM/IN not captured standing pages 46, 47, 49, 50 · source
Procedural sedation peds 2 mcg/kg IV/IM/IN not captured standing pages 49, 50 · source

Furosemide

IndicationPopulationDoseRouteRepeatStandingSource
CHF / pulmonary edema adult 80 mg IV not captured standing pages 99, 98 · source
G–L Glucagon, Haloperidol, Hydrocortisone, Hydroxocobalamin, Ibuprofen, Ipratropium, Ketamine, Ketorolac, Levalbuterol, Levetiracetam, Lidocaine, Lorazepam12

Glucagon

IndicationPopulationDoseRouteRepeatStandingSource
Anaphylaxis adult 1–4 mg IV not captured standing pages 36, 37 · source
Beta-blocker / calcium-channel-blocker overdose adult 1–5 mg IV not captured standing pages 161, 164, 165 · source
Beta-blocker / calcium-channel-blocker overdose adult 1–5 mg IV not captured standing pages 161, 164, 165 · source
Beta-blocker / calcium-channel-blocker overdose peds 0.1 mg/kg IV not captured standing pages 161, 164, 165 · source
Beta-blocker / calcium-channel-blocker overdose peds 0.1 mg/kg IV not captured standing pages 161, 164, 165 · source
Hypoglycemia adult 1 mg IM not captured standing pages 61, 62 · source
Hypoglycemia adult 3 mg IN not captured standing page 61 · source
Hypoglycemia peds 0.1 mg/kg IM not captured standing pages 61, 62 · source

Haloperidol

IndicationPopulationDoseRouteRepeatStandingSource
Agitation adult 5–10 mg IV/IM not captured standing page 95 · source
Agitation adult 5–10 mg IV/IM not captured standing page 59 · source

Hydrocortisone

IndicationPopulationDoseRouteRepeatStandingSource
Adrenal crisis adult 100 mg IV not captured standing page 34 · source
Adrenal crisis peds 2 mg/kg IV not captured standing page 34 · source
Anaphylaxis adult 100 mg IV not captured standing pages 36, 37, 40, 41 · source
Anaphylaxis peds 2 mg/kg IV not captured standing pages 36, 37, 40, 41 · source
Asthma / bronchospasm adult 100 mg IV not captured standing pages 55, 56 · source
Asthma / bronchospasm peds 2 mg/kg IV not captured standing pages 55, 56 · source

Hydroxocobalamin

IndicationPopulationDoseRouteRepeatStandingSource
Cyanide poisoning adult 70 mg/kg IV not captured standing pages 161, 162, 164, 165 · source
Cyanide poisoning peds 70 mg/kg IV not captured standing pages 161, 162, 164, 165 · source

Ibuprofen

IndicationPopulationDoseRouteRepeatStandingSource
Fever adult 400–800 mg PO not captured standing pages 68, 69 · source
Fever peds 10 mg/kg PO not captured standing pages 68, 69 · source
Mild to moderate pain adult 400–800 mg PO not captured standing pages 46, 49 · source
Mild to moderate pain peds 10 mg/kg PO not captured standing pages 46, 49 · source

Ipratropium

IndicationPopulationDoseRouteRepeatStandingSource
Anaphylaxis adult 500 mcg NEB not captured standing pages 35, 36, 37, 39, 40, 41 · source
Anaphylaxis peds 500 mcg NEB not captured standing pages 35, 36, 37, 39, 40, 41 · source
Asthma / bronchospasm adult 500 mcg NEB not captured standing pages 53, 55, 56 · source
Asthma / bronchospasm peds 500 mcg NEB not captured standing pages 53, 55, 56 · source

Ketamine

IndicationPopulationDoseRouteRepeatStandingSource
Agitation adult 1 mg/kg IV not captured standing page 59 · source
Agitation adult 2 mg/kg IM not captured standing page 59 · source
Agitation adult 2 mg/kg IV not captured standing page 95 · source
Agitation adult 2 mg/kg IM not captured standing page 95 · source
Agitation peds 2 mg/kg IV not captured standing page 95 · source
Agitation peds 2 mg/kg IM not captured standing page 95 · source
Mild to moderate pain adult 0.1–0.25 mg/kg IV not captured standing pages 47, 50 · source
Mild to moderate pain adult 0.25–0.5 mg/kg IM/IN not captured standing pages 47, 50 · source
Mild to moderate pain peds 0.1 mg/kg IV not captured standing pages 47, 50 · source
Mild to moderate pain peds 0.2 mg/kg IM/IN not captured standing pages 47, 50 · source
Procedural sedation peds 0.5–1 mg/kg IV not captured standing pages 47, 50 · source
Procedural sedation peds 2 mg/kg IM not captured standing pages 47, 50 · source
RSI induction adult 1 mg/kg IV not captured standing pages 186, 187 · source
RSI induction peds 1–2 mg/kg IV not captured standing pages 186, 187 · source

Ketorolac

IndicationPopulationDoseRouteRepeatStandingSource
Mild to moderate pain adult 15 mg IV not captured standing pages 47, 50 · source
Mild to moderate pain adult 30 mg IM not captured standing pages 47, 50 · source
Mild to moderate pain peds 0.5 mg/kg IV not captured standing pages 47, 50 · source
Mild to moderate pain peds 0.5 mg/kg IM not captured standing pages 47, 50 · source

Levalbuterol

IndicationPopulationDoseRouteRepeatStandingSource
Respiratory distress adult 1.25 mg NEB not captured standing page 53 · source
Respiratory distress adult 1.25 mg MDI not captured standing page 53 · source

Levetiracetam

IndicationPopulationDoseRouteRepeatStandingSource
Seizure adult 20 mg/kg IV not captured standing pages 77, 79 · source
Seizure peds 20 mg/kg IV not captured standing pages 77, 79 · source

Lidocaine

IndicationPopulationDoseRouteRepeatStandingSource
VF / pulseless VT adult 100 mg IV/IO not captured standing pages 104, 105, 112, 113, 124, 126 · source
VF / pulseless VT peds 1 mg/kg IV/IO not captured standing pages 104, 105, 112, 113, 124, 126 · source

Lorazepam

IndicationPopulationDoseRouteRepeatStandingSource
Other adult 1 mg IV not captured standing pages 161, 162 · source
Other adult 1–2 mg IV not captured standing page 47 · source
Procedural sedation adult 1–2 mg IV/IM not captured standing page 47 · source
Seizure adult 2 mg IV/IM not captured standing pages 77, 79 · source
Seizure peds 0.1 mg/kg IV/IM not captured standing pages 77, 79 · source
M–O Magnesium Sulfate, Methylprednisolone, Metoprolol, Midazolam, Naloxone, Nitroglycerin, Norepinephrine, Ondansetron, Oral Glucose, Oxymetazoline, Oxytocin11

Magnesium Sulfate

IndicationPopulationDoseRouteRepeatStandingSource
Asthma / bronchospasm adult 2 g IV not captured standing pages 53, 56 · source
Asthma / bronchospasm peds 40 mg/kg IV not captured standing pages 53, 56 · source
Other adult 4 g IV not captured standing page 76 · source
Wide-complex tachycardia adult 1–2 g IV not captured standing pages 105, 113, 124, 126 · source
Wide-complex tachycardia peds 50 mg/kg IV not captured standing pages 105, 113, 124, 126 · source

Methylprednisolone

IndicationPopulationDoseRouteRepeatStandingSource
Adrenal crisis adult 125 mg IV not captured standing page 34 · source
Adrenal crisis peds 2 mg/kg IV not captured standing page 34 · source
Anaphylaxis adult 125 mg IV not captured standing pages 36, 37, 40, 41 · source
Anaphylaxis peds 2 mg/kg IV not captured standing pages 36, 37, 40, 41 · source
Asthma / bronchospasm adult 125 mg IV not captured standing pages 53, 55, 56 · source
Asthma / bronchospasm peds 2 mg/kg IV not captured standing pages 53, 55, 56 · source

Metoprolol

IndicationPopulationDoseRouteRepeatStandingSource
Other adult 5 mg IV not captured standing page 105 · source
Narrow-complex tachycardia adult 2.5–5 mg IV not captured standing page 120 · source

Midazolam

IndicationPopulationDoseRouteRepeatStandingSource
Agitation adult 2.5–5 mg IV/IM/IN not captured standing page 59 · source
Agitation adult 2.5–5 mg IV/IM/IN not captured standing page 95 · source
Agitation peds 2.5–5 mg IV/IM/IN not captured standing page 95 · source
Other adult 2.5–5 mg IV not captured standing page 47 · source
Procedural sedation adult 2.5–5 mg IV/IM/IN not captured standing pages 46, 47, 49, 50, 120, 122, 124, 126 · source
Procedural sedation peds 0.1 mg/kg IV/IM/IN not captured standing pages 46, 47, 49, 50, 120, 122, 124, 126 · source
Seizure adult 2.5 mg IV/IM/IN not captured standing pages 77, 79 · source
Seizure adult 2.5–5 mg IM/IN not captured standing pages 77, 79 · source
Seizure peds 0.1 mg/kg IM/IN not captured standing pages 77, 79 · source
Seizure peds 0.1 mg/kg IV/IM/IN not captured standing pages 77, 79 · source

Naloxone

IndicationPopulationDoseRouteRepeatStandingSource
Opioid overdose adult 0.4 mg IV/IM not captured standing page 164 · source
Opioid overdose adult 0.4–4 mg IN not captured standing pages 161, 164 · source
Opioid overdose peds 0.1 mg/kg IN not captured standing pages 161, 164 · source
Opioid overdose peds 0.1 mg/kg IV/IM not captured standing page 164 · source

Nitroglycerin

IndicationPopulationDoseRouteRepeatStandingSource
ACS / chest pain adult 0.3–0.4 mg SL not captured standing page 100 · source
CHF / pulmonary edema adult 0.4 mg SL not captured standing page 98 · source

Norepinephrine

IndicationPopulationDoseRouteRepeatStandingSource
Hypotension / shock adult 2–20 mcg IV not captured standing pages 81, 82, 83, 84 · source
Hypotension / shock peds 0.1–2 mcg/kg IV not captured standing pages 81, 82, 83, 84 · source
Sepsis adult 2–20 mcg IV not captured standing pages 89, 91 · source
Sepsis peds 0.1–2 mcg/kg IV not captured standing pages 89, 91 · source
Tricyclic overdose adult 2–20 mcg IV not captured standing pages 162, 165 · source
Tricyclic overdose peds 0.1–2 mcg/kg IV not captured standing pages 162, 165 · source

Ondansetron

IndicationPopulationDoseRouteRepeatStandingSource
Nausea / vomiting adult 4 mg IV/IM/PO/SL/ODT not captured standing pages 46, 47, 49, 50 · source
Nausea / vomiting peds 0.2 mg/kg IV/IM/PO/SL/ODT not captured standing pages 46, 47, 49, 50 · source
Other adult 4 mg IV/PO/ODT not captured standing page 150 · source
Other peds 0.2 mg/kg IV/PO/ODT not captured standing page 150 · source

Oral Glucose

IndicationPopulationDoseRouteRepeatStandingSource
Hypoglycemia adult 15 g PO not captured standing pages 61, 62 · source
Hypoglycemia peds 15 g PO not captured standing pages 61, 62 · source

Oxymetazoline

IndicationPopulationDoseRouteRepeatStandingSource
Other adult 2 spray IN not captured standing page 67 · source
Other adult 2 spray IN not captured standing page 158 · source

Oxytocin

IndicationPopulationDoseRouteRepeatStandingSource
Obstetric hemorrhage adult 10–20 unit IM not captured standing page 76 · source
Obstetric hemorrhage adult 20 unit IV not captured standing page 76 · source
P–R Phenylephrine, Pralidoxime, Prednisone, Procainamide, Proparacaine, Pseudoephedrine, Rocuronium7

Phenylephrine

IndicationPopulationDoseRouteRepeatStandingSource
Hypotension / shock adult 50–100 mcg IV not captured standing pages 83, 84, 283, 284 · source
Trauma / hemorrhage adult 100 mcg IV not captured standing pages 85, 86, 87 · source
Trauma / hemorrhage peds 5 mcg/kg IV not captured standing pages 85, 86, 87 · source

Pralidoxime

IndicationPopulationDoseRouteRepeatStandingSource
Nerve agent exposure adult 600 mg IV/IM not captured standing pages 166, 167 · source
Nerve agent exposure peds 15–25 mg/kg IV/IM not captured standing pages 166, 167 · source

Prednisone

IndicationPopulationDoseRouteRepeatStandingSource
Allergic reaction adult 60 mg PO not captured standing pages 37, 41 · source
Allergic reaction peds 2 mg/kg PO not captured standing pages 37, 41 · source

Procainamide

IndicationPopulationDoseRouteRepeatStandingSource
Wide-complex tachycardia adult 25–50 mg IV not captured standing page 124 · source

Proparacaine

IndicationPopulationDoseRouteRepeatStandingSource
Burns adult 2 drop OPH not captured standing page 150 · source
Burns peds 2 drop OPH not captured standing page 150 · source
Other adult 2 drop OPH not captured standing page 150 · source
Other peds 2 drop OPH not captured standing page 150 · source

Pseudoephedrine

IndicationPopulationDoseRouteRepeatStandingSource
Other adult 30 mg PO not captured standing page 158 · source

Rocuronium

IndicationPopulationDoseRouteRepeatStandingSource
Other adult 1 mg/kg IV not captured standing pages 47, 51 · source
Other peds 1 mg/kg IV not captured standing pages 47, 51 · source
RSI induction adult 1.2 mg/kg IV not captured standing pages 186, 187 · source
RSI induction peds 1.2 mg/kg IV not captured standing pages 186, 187 · source
S–Z Sodium Bicarbonate, Sodium Thiosulfate, Succinylcholine, Tetracaine, Thiamine, Tranexamic Acid, Vecuronium7

Sodium Bicarbonate

IndicationPopulationDoseRouteRepeatStandingSource
Crush injury adult 150 mEq IV not captured standing page 147 · source
Crush injury peds 150 mEq IV not captured standing page 147 · source
Hyperkalemia adult 50 mEq IV not captured standing pages 63, 147 · source
Other adult 50 mEq IV not captured standing pages 161, 162, 164, 165 · source
Other peds 1 mEq/kg IV not captured standing pages 161, 162, 164, 165 · source

Sodium Thiosulfate

IndicationPopulationDoseRouteRepeatStandingSource
Cyanide poisoning adult 12.5 g IV not captured standing page 162 · source

Succinylcholine

IndicationPopulationDoseRouteRepeatStandingSource
RSI induction adult 1.5 mg/kg IV not captured standing pages 186, 187 · source
RSI induction peds 2 mg/kg IV not captured standing pages 186, 187 · source

Tetracaine

IndicationPopulationDoseRouteRepeatStandingSource
Burns adult 2 drop OPH not captured standing page 150 · source
Burns peds 2 drop OPH not captured standing page 150 · source
Other adult 2 drop OPH not captured standing page 150 · source
Other peds 2 drop OPH not captured standing page 150 · source

Thiamine

IndicationPopulationDoseRouteRepeatStandingSource
Hypoglycemia adult 200 mg IV/IM not captured standing page 61 · source

Tranexamic Acid

IndicationPopulationDoseRouteRepeatStandingSource
Trauma / hemorrhage adult 2 g IV not captured standing pages 85, 87 · source
Trauma / hemorrhage peds 15 mg/kg IV not captured standing pages 85, 87 · source

Vecuronium

IndicationPopulationDoseRouteRepeatStandingSource
Other adult 0.1 mg/kg IV not captured standing pages 47, 51 · source
Other peds 0.1 mg/kg IV not captured standing pages 47, 51 · source
Cite this

Rhode Island Department of Health – Center for Emergency Medical Services, United States EMS Protocol Census. 219 dose entries, effective 2026-06-01.

https://protoquiz.com/census/agencies/rhode-island-department-of-health-center-for-emergency-medical-services/

Outdated or wrong? Fix or remove itAll Rhode Island agenciesMethodologyData licenseStudy these protocols in the app

The census is free and not for sale. Only public agencies are named.

Training reference compiled from published protocols. Not a clinical order. Verify with your agency and medical director.